The Aquilion Prime 80 features the AIDR 3D dose reduction software.
Toshiba America Medical Systems Inc. has received FDA clearance for the latest in its Aquilion CT product line, the Aquilion Prime 80 series, the company announced Monday.
The system, which features their Adaptive Iterative Dose Reduction 3D software, can generate 80 unique slices per rotation and is designed with in-field upgradeability to 160 slices, the company said.
The Aquilion Prime features a 0.5 mm detector, a 7.5 MHU large-capacity tube and 0.35 second scanning. The system also includes a 78 cm aperture gantry and a 660-pound patient-weight-capacity couch. In addition to the AIDR 3D software, the system comes with Nema XR 25 Dose Check Software which includes dose alert and notification features.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.